These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 22623630)
1. Antibiotic management and early discharge from hospital: an economic analysis. Gray A; Dryden M; Charos A J Antimicrob Chemother; 2012 Sep; 67(9):2297-302. PubMed ID: 22623630 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. Dryden M; Saeed K; Townsend R; Winnard C; Bourne S; Parker N; Coia J; Jones B; Lawson W; Wade P; Howard P; Marshall S J Antimicrob Chemother; 2012 Sep; 67(9):2289-96. PubMed ID: 22623629 [TBL] [Abstract][Full Text] [Related]
4. Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections. Revankar N; Ward AJ; Pelligra CG; Kongnakorn T; Fan W; LaPensee KT J Med Econ; 2014 Oct; 17(10):730-40. PubMed ID: 25019580 [TBL] [Abstract][Full Text] [Related]
5. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Roberts RR; Hota B; Ahmad I; Scott RD; Foster SD; Abbasi F; Schabowski S; Kampe LM; Ciavarella GG; Supino M; Naples J; Cordell R; Levy SB; Weinstein RA Clin Infect Dis; 2009 Oct; 49(8):1175-84. PubMed ID: 19739972 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic policy. Gyssens IC Int J Antimicrob Agents; 2011 Dec; 38 Suppl():11-20. PubMed ID: 22018989 [TBL] [Abstract][Full Text] [Related]
7. Cost of Gram-negative resistance. Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877 [TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623 [TBL] [Abstract][Full Text] [Related]
9. [Potential antibiotic pharmaceutical cost reduction in an operative unit of infectious diseases. Projects for making savings and improvements]. Sabbatani S; Cesari R; Pipitone E Infez Med; 2001 Sep; 9(3):137-46. PubMed ID: 12084987 [TBL] [Abstract][Full Text] [Related]
10. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section. Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036 [TBL] [Abstract][Full Text] [Related]
11. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135 [TBL] [Abstract][Full Text] [Related]
12. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997 [TBL] [Abstract][Full Text] [Related]
13. Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery. Wilson SE; Turpin RS; Kumar RN; Itani KM; Jensen EH; Pellissier JM; Abramson MA Surg Infect (Larchmt); 2008 Jun; 9(3):349-56. PubMed ID: 18570576 [TBL] [Abstract][Full Text] [Related]
14. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital. Mach R; Vlcek J; Prusova M; Batka P; Rysavy V; Kubena A Pharm World Sci; 2007 Oct; 29(5):565-72. PubMed ID: 17610145 [TBL] [Abstract][Full Text] [Related]
15. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B; BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073 [TBL] [Abstract][Full Text] [Related]
16. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study. Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456 [TBL] [Abstract][Full Text] [Related]
17. Economic impact of hospitalisations among patients in the last year of life: an observational study. Gardiner C; Ward S; Gott M; Ingleton C Palliat Med; 2014 May; 28(5):422-9. PubMed ID: 24367059 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic use and cost indicators at a rural hospital: a pilot project. Mylotte JM; Weislo P Am J Infect Control; 2000 Dec; 28(6):415-20. PubMed ID: 11114611 [TBL] [Abstract][Full Text] [Related]
19. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis. Jackson J; Fernandes AW; Nelson W Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318 [TBL] [Abstract][Full Text] [Related]
20. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center. Mansouri MD; Cadle RM; Agbahiwe SO; Musher DM Infection; 2011 Feb; 39(1):53-8. PubMed ID: 21318422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]